BTIG Reiterates Buy Rating on Praxis Precision Medicines, Inc. (PRAX)

Market Context

Praxis Precision Medicines, Inc. operates in the Healthcare sector. The stock currently trades at $291.03 with a market capitalization of $5.7B.

Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Praxis Precision Medicines, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Praxis Precision Medicines, Inc.

Among the 10 most recent ratings: 9 Buy, 0 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 29, 2026	BTIG	Buy	N/A
Jul 13, 2026	Goldman Sachs	Buy	N/A
Jun 29, 2026	Needham	Buy	N/A
Jun 18, 2026	RBC Capital	Outperform	N/A
Jun 02, 2026	Truist Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View PRAX Stock Page